2019~2024年全球多囊卵巢综合征随机对照实验文献计量学和可视化分析
Literature Metrology and Visualization Analysis of Global Randomized Controlled Experiments on Polycystic Ovary Syndrome from 2019 to 2024
摘要: 目的：分析近6年多囊卵巢综合征随机对照研究特点，为临床应用和未来研究提供参考。方法：检索2019~2024年发表在Web of Science的多囊卵巢综合征随机对照研究，对文献基本要素开展计量学分析。结果：共纳入204篇随机对照研究，尽管2023年相关文献较少，近6年多囊卵巢综合症相关随机对照研究年度发文趋势较为稳定，平均年度发文量为34篇。发文量最多的为中科院分区生殖生物学2区杂志《JOURNAL OF OVARIAN RESEARCH》，近6年共计发表PCOS相关RCT研究10篇。影响因子最高的杂志为《LANCET DIABETES & ENDOCRINOLOGY》，目前影响因子为44分。并进一步对主要结局指标和主要干预措施进行可视化分析。
Abstract: Aim: Analyze the characteristics of randomized controlled studies of polycystic ovary syndrome in the past 6 years, which provides reference for clinical application and future research. Methods: Retrieve the randomized controlled study of polycystic ovary syndrome published in the Web of Science from 2019 to 2024, and carried out a metric analysis of the basic elements of the literature. Results: A total of 204 randomized controlled studies were included. Although there were fewer relevant literature in 2023, the annual trend of published randomized controlled studies on polycystic ovary syndrome in the past 6 years was relatively stable, with an average annual published volume of 34 articles. The largest number of articles is “JOURNAL OF OVARIAN RESEARCH”, a journal of distinct 2 of reproductive biology of the Chinese academy of science, which has published a total of 10 PCOS-related RCT research in the past six years. The journal with the highest impact factor is “LANCET DIABETES & ENDOCRINOLOGY”, with a current impact factor of 44 points. And further visualize and analyze the main outcome indicators and main interventions.
文章引用：马烨婷, 杨竹. 2019~2024年全球多囊卵巢综合征随机对照实验文献计量学和可视化分析[J]. 临床医学进展, 2025, 15(5): 1212-1225. https://doi.org/10.12677/acm.2025.1551484

参考文献

[1] Banaszewska, B., Pawelczyk, L. and Spaczynski, R. (2019) Current and Future Aspects of Several Adjunctive Treatment Strategies in Polycystic Ovary Syndrome. Reproductive Biology, 19, 309-315. [Google Scholar] [CrossRef] [PubMed]
[2] Laven, J.S.E., Imani, B., Eijkemans, M.J.C. and Fauser, B.C.J.M. (2002) New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility. Obstetrical & Gynecological Survey, 57, 755-767. [Google Scholar] [CrossRef] [PubMed]
[3] Bhide, A., Shah, P.S. and Acharya, G. (2018) A Simplified Guide to Randomized Controlled Trials. Acta Obstetricia et Gynecologica Scandinavica, 97, 380-387. [Google Scholar] [CrossRef] [PubMed]
[4] Gu, D., Li, J., Li, X. and Liang, C. (2017) Visualizing the Knowledge Structure and Evolution of Big Data Research in Healthcare Informatics. International Journal of Medical Informatics, 98, 22-32. [Google Scholar] [CrossRef] [PubMed]
[5] van Eck, N.J. and Waltman, L. (2009) Software Survey: Vosviewer, a Computer Program for Bibliometric Mapping. Scientometrics, 84, 523-538. [Google Scholar] [CrossRef] [PubMed]
[6] Mehta, R. and Varma, H. (2019) 787-P: Prevalence of Metabolic Syndrome in Indian Women with Polycystic Ovarian Syndrome (PCOS) and the Correlation of Dietary Nutrient Composition and Physical Activity on Components of the PCOS—A Pilot Study. Diabetes, 68, 787-P. [Google Scholar] [CrossRef] 
[7] Wojciechowska, A., Osowski, A., Jóźwik, M., Górecki, R., Rynkiewicz, A. and Wojtkiewicz, J. (2019) Inositols’ Importance in the Improvement of the Endocrine-Metabolic Profile in PCOs. International Journal of Molecular Sciences, 20, Article 5787. [Google Scholar] [CrossRef] [PubMed]
[8] Nestler, J.E. and Unfer, V. (2015) Reflections on Inositol(s) for PCOS Therapy: Steps toward Success. Gynecological Endocrinology, 31, 501-505. [Google Scholar] [CrossRef] [PubMed]
[9] Farrell, K. and Antoni, M.H. (2010) Insulin Resistance, Obesity, Inflammation, and Depression in Polycystic Ovary Syndrome: Biobehavioral Mechanisms and Interventions. Fertility and Sterility, 94, 1565-1574. [Google Scholar] [CrossRef] [PubMed]
[10] Osibogun, O., Ogunmoroti, O. and Michos, E.D. (2020) Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention. Trends in Cardiovascular Medicine, 30, 399-404. [Google Scholar] [CrossRef] [PubMed]
[11] Zeng, X., Xie, Y., Liu, Y., Long, S. and Mo, Z. (2020) Polycystic Ovarian Syndrome: Correlation between Hyperandrogenism, Insulin Resistance and Obesity. Clinica Chimica Acta, 502, 214-221. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Y., Tan, J., Wang, Q., Duan, C., Hu, Y. and Huang, W. (2020) Comparing the Individual Effects of Metformin and Rosiglitazone and Their Combination in Obese Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial. Fertility and Sterility, 113, 197-204. [Google Scholar] [CrossRef] [PubMed]
[13] Macut, D., Bjekić-Macut, J., Rahelić, D. and Doknić, M. (2017) Insulin and the Polycystic Ovary Syndrome. Diabetes Research and Clinical Practice, 130, 163-170. [Google Scholar] [CrossRef] [PubMed]
[14] Katulski, K., Czyzyk, A., Podfigurna-Stopa, A., Genazzani, A.R. and Meczekalski, B. (2014) Pregnancy Complications in Polycystic Ovary Syndrome Patients. Gynecological Endocrinology, 31, 87-91. [Google Scholar] [CrossRef] [PubMed]
[15] Ashoush, S., Abou‐Gamrah, A., Bayoumy, H. and Othman, N. (2015) Chromium Picolinate Reduces Insulin Resistance in Polycystic Ovary Syndrome: Randomized Controlled Trial. Journal of Obstetrics and Gynaecology Research, 42, 279-285. [Google Scholar] [CrossRef] [PubMed]
[16] Penzias, A., Bendikson, K., Butts, S., Coutifaris, C., Falcone, T., Fossum, G., et al. (2017) Role of Metformin for Ovulation Induction in Infertile Patients with Polycystic Ovary Syndrome (PCOS): A Guideline. Fertility and Sterility, 108, 426-441. [Google Scholar] [CrossRef] [PubMed]
[17] McCartney, C.R. and Marshall, J.C. (2016) Polycystic Ovary Syndrome. The New England Journal of Medicine, 375, 54-64.
[18] Balen, A.H., Morley, L.C., Misso, M., Franks, S., Legro, R.S., Wijeyaratne, C.N., et al. (2016) The Management of Anovulatory Infertility in Women with Polycystic Ovary Syndrome: An Analysis of the Evidence to Support the Development of Global WHO Guidance. Human Reproduction Update, 22, 687-708. [Google Scholar] [CrossRef] [PubMed]
[19] Wekker, V., van Dammen, L., Koning, A., Heida, K.Y., Painter, R.C., Limpens, J., et al. (2020) Long-Term Cardiometabolic Disease Risk in Women with PCOS: A Systematic Review and Meta-Analysis. Human Reproduction Update, 26, 942-960. [Google Scholar] [CrossRef] [PubMed]
[20] Greff, D., Juhász, A.E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., et al. (2023) Inositol Is an Effective and Safe Treatment in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reproductive Biology and Endocrinology, 21, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[21] Azizi Kutenaei, M., Hosseini Teshnizi, S., Ghaemmaghami, P., Eini, F. and Roozbeh, N. (2021) The Effects of Myo-inositol vs. Metformin on the Ovarian Function in the Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. European Review for Medical and Pharmacological Sciences, 25, 3105-3115.
[22] Gudović, A., Bukumirić, Z., Milincic, M., Pupovac, M., Andjić, M., Ivanovic, K., et al. (2024) The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome. Biomedicines, 12, Article 349. [Google Scholar] [CrossRef] [PubMed]
[23] Facchinetti, F., Unfer, V., Dewailly, D., Kamenov, Z.A., Diamanti-Kandarakis, E., Laganà, A.S., et al. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism, 31, 435-447. [Google Scholar] [CrossRef] [PubMed]
[24] Waghmare, S.V. and Shanoo, A. (2023) Polycystic Ovary Syndrome: A Literature Review with a Focus on Diagnosis, Pathophysiology, and Management. Cureus, 15, e47408. [Google Scholar] [CrossRef] [PubMed]
[25] Sanchez-Garrido, M.A. and Tena-Sempere, M. (2020) Metabolic Dysfunction in Polycystic Ovary Syndrome: Pathogenic Role of Androgen Excess and Potential Therapeutic Strategies. Molecular Metabolism, 35, Article ID: 100937. [Google Scholar] [CrossRef] [PubMed]
[26] Anagnostis, P., Tarlatzis, B.C. and Kauffman, R.P. (2018) Polycystic Ovarian Syndrome (PCOS): Long-Term Metabolic Consequences. Metabolism, 86, 33-43. [Google Scholar] [CrossRef] [PubMed]
[27] Zilaee, M., Mansoori, A., Ahmad, H.S., Mohaghegh, S.M., Asadi, M. and Hormoznejad, R. (2020) The Effects of Soy Isoflavones on Total Testosterone and Follicle-Stimulating Hormone Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. The European Journal of Contraception & Reproductive Health Care, 25, 305-310. [Google Scholar] [CrossRef] [PubMed]

为你推荐